Apotex Inc.

In News

APOTEX HEALTH CORP. ANNOUNCES UPSIZE OF BOUGHT DEAL SECONDARY OFFERING TO $850 MILLION - Yahoo! Finance Canada

Yahoo! Finance Canada - Sep 15, 2026

Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals - PR Newswire

PR Newswire - Jul 01, 2026

Apotex Health seeks to raise up to C$1.2 billion, potentially reviving Toronto IPO market - Reuters

Reuters - Jun 01, 2026

Apotex Shares Rally as Trading Begins Following Pricing of C$1.3 Billion IPO - WSJ

WSJ - Jun 10, 2026

Apotex Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Revelio Labs - Jul 28, 2026

APOTEX HEALTH CORP. ANNOUNCES $750 MILLION BOUGHT DEAL SECONDARY OFFERING - Yahoo! Finance Canada

Yahoo! Finance Canada - Sep 14, 2026

Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada - PR Newswire

PR Newswire - May 14, 2026

Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry - Reuters

Reuters - May 21, 2026

RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities - PR Newswire

PR Newswire - Aug 31, 2026

APOTEX HEALTH CORP. UPSIZES ITS INITIAL PUBLIC OFFERING - Yahoo Finance

Yahoo Finance - Jun 08, 2026

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic® - PR Newswire

PR Newswire - May 01, 2026

Apotex expands ophthalmic portfolio with Health Canada approval of IHEEZO™ - Yahoo! Finance Canada

Yahoo! Finance Canada - May 26, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment